Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sortreated patients (pts): Clinical findings in pts with liver dysfunction
Marrero Jorge A.,Lencioni Riccardo,Ye Sheng-Long,et al.Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sortreated patients (pts): Clinical findings in pts with liver dysfunction[J].JOURNAL OF CLINICAL ONCOLOGY.2013,31(15):
APA:
Marrero, Jorge A.,Lencioni, Riccardo,Ye, Sheng-Long,Kudo, Masatoshi,Bronowicki, Jean-Pierre...&Venook, Alan Paul.(2013).Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sortreated patients (pts): Clinical findings in pts with liver dysfunction.JOURNAL OF CLINICAL ONCOLOGY,31,(15)
MLA:
Marrero, Jorge A.,et al."Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sortreated patients (pts): Clinical findings in pts with liver dysfunction".JOURNAL OF CLINICAL ONCOLOGY 31..15(2013)